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[ 1  ]  J  a  m  e  s  B  D  ,  L  e  u  r  g  a  n  s  S  E  ,  H  e  b  e  r  t  L  E  ,  S  c  h  e  r  r  P  A  ,  Y  a  f  f  e  K  ,  B  e  n  n  e  t  t  D  A  .  C  o  n  t  r  i  b  u  t  i  o  n  o  f  A  l  z  h  e  i  m  e  r  d  i  s  e  a  s  e  t  o  m  o  r  t  a  l  i  t  y  i  n  7  3   t  h  e  U  n  i  t  e  d  S  t  a  t  e  s  .  N  e  u  r  o  l  o  g  y  2  0  1  4  ;  8  2  :  1  0  4  5  -5  0  .  d  o  i  :  1  0  .  1  2  1  2  /  W  N  L  .  0  0  0  0  0  0  0  0  0  0  0  0  0  2  4  0  .  7  4   [  2  ]  R  i  d  g  e  P  G  ,  M  u  k  h  e  r  j  e  e  S  ,  C  r  a  n  e  P  K  ,  K  a  u  w  e  J  S  K  ,  A  l  z  h  e  i  m  e  r  '  s  D  i  s  e  a  s  e  G  e  n  e  t  i  c  s  C  o  n  s  o  r  t  i  u  m  .  A  l  z  h  e  i  m  e  r  '  s  D  i  s  e  a  s  e  :  7 variants are independent (i.e., there is no synergistic, or non-linear effect on the phenotype) while the observed odds ratio 2 2 (numerator) is the actual effect. A synergy factor that deviates from 1 indicates a statistical interaction between the 2 3 variants that affects the phenotype. 
